How much information can metabolic syndrome provide? An application of information theory

Medical Decision Making

Volumn 31, Issue 1, 2011, Pages 79-92

  Beckstead, Jason W ^a   Beckie, Theresa M ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Dichotomization; Information theory; Metabolic syndrome

Indexed keywords

CHOLESTEROL;

ARTICLE; EXERCISE TOLERANCE; FEMALE; GENETICS; HUMAN; INFORMATION DISSEMINATION; INFORMATION SCIENCE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PATHOLOGY; PHENOTYPE; RISK ASSESSMENT; UNCERTAINTY;

CHOLESTEROL; EXERCISE TOLERANCE; FEMALE; HUMANS; INFORMATION DISSEMINATION; INFORMATION THEORY; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PHENOTYPE; RISK ASSESSMENT; UNCERTAINTY;

EID: 79953864235     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X10373401     Document Type: Article

References (36)

1. Shannon CE. A mathematical theory of communication. Bell Syst Tech J. 1948;27:379-423, 623-56.
2. Shannon CE, Weaver W. The Mathematical Theory of Communication. Urbana, IL: University of Illinois Press; 1949.
3. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol. 2006;21(1):1-6. (Pubitemid 43194325)
4. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-607. (Pubitemid 19004941)
5. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-53. (Pubitemid 28319935)
6. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16(5):442-3.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97.
8. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet. 2005;366(9491):1059-62. (Pubitemid 41338752)
9. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr. 2006;83(6):1237-47. (Pubitemid 44713049)
10. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28(9):2289-304.
11. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004;27(11):2676-81. (Pubitemid 39441469)
12. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881-7. (Pubitemid 46024995)
13. Ezzati M, Oza S, Danaei G, Murray CJL. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States. Circulation. 2008;117: 905-14. (Pubitemid 351272588)
14. US Department of Health and Human Services. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No. 04-5230. Washington, DC: Author; 2004.
15. Lord FM, Novick MR. Statistical Theories of Mental Test Scores. Reading, MA: Addison-Wesley; 1968.
16. Beckie TM. A behavior change intervention for women in cardiac rehabilitation. J Cardiovasc Nurs. 2006;21(2):146-53.
17. Beckie TM, Fletcher GF, Beckstead JW, Schocken DD, Evans ME. Adverse baseline physiological and psychological profiles of women enrolled in a cardiac rehabilitation clinical trial. J Cardiopulm Rehabil Prev. 2008;28(1):52-60. (Pubitemid 351284419)
18. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Circulation. 2005;111(5):697-716. (Pubitemid 40216499)
19. Fletcher GF, Balady GJ, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards: a statement for healthcare professionals from the American Heart Association. Circulation. 1995;91(2):580-615.
20. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2002;106(14): 1883-92.
21. Hsich E, Gorodeski EZ, Starling RC, Blackstone EH, Ishwaran H, Laurer MS. Importance of treadmill exercise time as an initial prognostic screening to in patients with systolic left ventricular dysfunction. Circulation. 2009;119:3189-97.
22. Gulati M, Pandey DK, Arnsdorf MF, et al. Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation. 2003;108:1554-9. (Pubitemid 37187780)
23. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation. 1991;83:356-62.
24. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. Third National Health and Nutrition Examination Survey (NHANES III), National Cholesterol Education Program. Diabetes. 2003;52:1210-4.
25. Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the Atherosclerosis Risk in Communities Study. Diabetes. 2002;51:3069-76.
26. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk for incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care. 2005;28:385-90. (Pubitemid 40170944)
27. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414-9. (Pubitemid 36935533)
28. Sattar N, McConnachie A, Shaper AG, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008;371: 1927-35.
29. Yarnell JWG, Patterson CC, Bainton D, Sweetnam PM. Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies. Heart. 1998;79:248-52. (Pubitemid 28212212)
30. Beckstead JW, Stamp KD. Understanding how nurse practitioners estimate patients' risk for coronary heart disease: a judgment analysis. J Adv Nurs. 2007;60(4):436-46.
31. Peters CC, Van Voorhis WR. Statistical Procedures and Their Mathematical Bases. New York: McGraw-Hill; 1940.
32. Cohen J. The cost of dichotomization. Appl Psychol Meas. 1983;7(3):247-53.
33. Maxwell SE, Delaney HD. Bivariate median splits and spurious statistical significance. Psychol Bull. 1993;113(1):181-90.
34. MacCallum RC, Zhang S, Preacher KJ, Rucker DD. On the practice of dichotomization of quantitative variables. Psychol Methods. 2002;7(1):19-40.
35. Fitzsimons GJ. Death to dichotomization. J Consum Res. 2008;35:5-8.
36. DeCoster J, Iselin AR, Gallucci M. A conceptual and empirical examination of justifications for dichotomization. Psychol Methods. 2009;14(4):349-66.